These findings suggest that NACT appears to preferentially increase the adjuvanticity of metastatic HGSOC, correlating with signs of increased tumor infiltration by immune effector cells including CD8+ CTLs and CD20+ B cells but not DC-LAMP+ DCs. The gene discussed is LAMP3; the disease is neoplasm.